CanGaroo® Registry Study

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

April 17, 2023

Study Completion Date

October 17, 2024

Conditions
Arrhythmias, Cardiac
Interventions
DEVICE

CanGaroo Envelope

Utilization of a CanGaroo envelope with the CIED during the participant's CIED implant procedure.

Trial Locations (23)

19104

University of Pennsylvania Hospital, Philadelphia

27607

UNC Health/NC Heart & Vascular Research, Raleigh

28401

New Hanover Regional Medical Center, Wilmington

29720

Carolina Heart Specialists, Lancaster

32114

Daytona Heart Group, Daytona Beach

32607

VA Medical Center, Gainesville

33308

Florida Heart Rhythm Specialists, PLLC, Fort Lauderdale

33484

The Arrhythmia Center of South Florida, Delray Beach

33613

Advent Health, Tampa

34741

Cardiovascular Associates/Osceola Regional Medical Center, Kissimmee

40504

St. Joseph Hospital, Lexington

43608

Mercy Health, Toledo

47150

Baptist Health Floyd, New Albany

48075

Ascension Providence Hospital, Southfield

48912

Sparrow Clinical Research Institute, Lansing

49519

Metro Health/University of Michigan Health, Wyoming

72211

Arkansas Heart Hospital, Little Rock

74127

Oklahoma State University Center for Health Sciences, Tulsa

77030

Houston Methodist, Houston

77380

Heart Rhythm Associates, The Woodlands

77555

University of Texas Medical Branch, Galveston

04401

Eastern Maine Medical Center, Bangor

02115

Brigham & Women's Hospital, Cardiovascular Division, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elutia Inc.

INDUSTRY

NCT04846127 - CanGaroo® Registry Study | Biotech Hunter | Biotech Hunter